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Editorial Comment 
Restenosis: The "Hole" Truth?* 
SPENCER B. KING III, MD, FACC 
Atlanta, Georgia 
Although restenosis has been recognized since the first days of 
angioplasty, much attention has recently been paid to the 
various mechanisms by which the lumen is narrowed. The 
ultimate long-range goal of angioplasty, however, was well 
recognized by the mayor of a small village in the Emmenthal 
Valley. The occasion was the third demonstration course on 
coronary angioplasty conducted by Dr. Andreas Gruentzig in 
Zurich; the time was January 1980; and the place was a 
picturesque Swiss village in the heart of the Emmenthal cheese 
country. As those physicians who had come from around the 
world gathered for a social evening, Andreas introduced the 
mayor of the small town to deliver a welcoming address. In 
schweizerdeutsch he concluded, "Angioplasty is like Swiss 
cheese--although the texture and taste are important, it is the 
holes that make it unique." Indeed in angioplasty, be it 
achieved by balloons, drills or stents, blood flow and myocar- 
dial perfusion depend on the hole. 
In the report by Mehta et al. (1) in this issue of the Journal, 
15 patients who had arteries with a shrinking hole the magni- 
tude of which would qualify for the usual definition of resten- 
osis experienced later enlargement of the hole through no 
medical intervention save time. Although this observation has 
been made by others, the ubiquitous resolution of this resten- 
osis in 15 patients i  surprising. 
Two major questions are raised. One is the question of 
science and the other a question of medicine and economics. 
The scientific question is, "What are the components of 
reduction in the size of the hole and of its ultimate xpansion 
in these patients?" Although Mehta et al. discuss the mecha- 
nisms of restenosis, including elastic recoil, thrombosis and 
neointimal formation, they do not speculate about chronic 
arterial constriction. Recent ultrasound observations (2) point 
to the major contribution of arterial constriction, and a few 
cases have suggested that that constriction may occur rather 
late in the healing phase. Experimental work suggests (3) that 
proliferation and migration of vascular smooth muscle cells 
and development of a lesion we call neointima may occur 
within the first few weeks. Observations in patients have also 
supported this idea. 
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Nobuyoshi et at. (4) showed that at 1 month there was little 
arterial narrowing, but at 3 months this had become substan- 
tial. Could the late phase (1 to 3 months) have as its major 
contributor constriction of the entire artery? Individual cases 
have suggested so, and another study by Nobuyoshi et al. is 
underway that should provide further insight into the relative 
contribution toloss of the hole by 3 months. The present study 
(1) shows that the hole may enlarge after the initial reduction. 
The mechanism of that event must also be studied. Hyperpla- 
sia after stent placement in experimental nimals peaks at -8 
weeks and regresses later. However, stents tabilize the artery, 
eliminating any possibility of changes in arterial dimensions. Is
the late improvement in the size of the hole due to reduction 
in the mass of neointima or enlargement of the artery, or both? 
Most research as been focused on reducing the develop- 
ment of the neointimal lesion. It is entirely possible that some of 
the failure to reduce stenosis with agents effective inexperimental 
animals may be due to the contribution of another mechanism-- 
late arterial constriction (a component of wound healing). 
The other provocative question raised by Mehta et al. is 
medical and economic: What does this finding mean for 
patients and society? Certainly the asymptomatic patient with- 
out major ischemia will gain very little from repeat dilation 
after discovery of restenosis. As their study shows (1), most of 
the patients experienced significant improvement i  the size of 
the hole in later follow-up. The authors peculate that this 
process may also be operative in patients who are symptomatic 
or exhibit significant ischemia. In many patients, the practice of 
redilation is often based on the assumption that the hole is 
getting progressively smaller and therefore one must act. Mehta 
et al. have challenged this concept, suggesting that in fact the hole 
may be getting larger, and therefore one should wait. If this 
approach proves afe and effective, as it has in some clinical 
observations (5), it could have significant positive conomic 
benefits by reducing the number of repeat interventions. 
As provocative as that approach isfor cost containment, the 
more exciting potential for future research lies in understand- 
ing the mechanism of change in the size of the hole, both 
during and after the restenotic phase. Perhaps for answers to 
these questions we should return to the Emmenthal Valley for 
additional advice from the mayor. 
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